Johnson City-based Crown Laboratories, a privately held, fully integrated global skincare company, announced yesterday that it is acquiring StriVectin, the No. 1 independent prestige skin care company in the U.S.
Launched in 2002 and based in New York City, StriVectin is ranked by consumers as the most effective anti-aging skincare brand. Upon completion of the transaction which is expected by mid-September, StriVectin’s products will become part of Crown’s new Premium Skincare Division and will operate as a wholly owned subsidiary of Crown Laboratories. Cori Aleardi, StriVectin’s President, will become President and Chief Commercial Officer of Crown and will join the Crown Executive Leadership Team. StriVectin will continue to be based in New York City.
Click here to read the announcement.